These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31875196)

  • 1. Relationship Between Pain Alleviation and Disease-specific Health-related Quality of Life Measures in Patients With Chronic Low Back Pain Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study.
    Enomoto H; Sasaki N; Fujikoshi S; Yoshikawa A; Tsuji T; Takeshita K
    J Am Acad Orthop Surg Glob Res Rev; 2019 Nov; 3(11):. PubMed ID: 31875196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Pain Reduction and Improvement in Health-Related Quality of Life in Patients with Knee Pain Due to Osteoarthritis Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study.
    Enomoto H; Fujikoshi S; Ogawa K; Tsuji T; Tanaka S
    J Pain Res; 2020; 13():181-191. PubMed ID: 32021407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to duloxetine in chronic low back pain: exploratory post hoc analysis of a Japanese Phase III randomized study.
    Tsuji T; Itoh N; Ishida M; Ochiai T; Konno S
    J Pain Res; 2017; 10():2157-2168. PubMed ID: 28919811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
    Konno SI; Alev L; Oda N; Ochiai T; Enomoto H
    Pain Med; 2019 Aug; 20(8):1479-1488. PubMed ID: 30856270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
    Konno S; Oda N; Ochiai T; Alev L
    Spine (Phila Pa 1976); 2016 Nov; 41(22):1709-1717. PubMed ID: 27831985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
    Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
    Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial.
    Skljarevski V; Zhang S; Desaiah D; Alaka KJ; Palacios S; Miazgowski T; Patrick K
    J Pain; 2010 Dec; 11(12):1282-90. PubMed ID: 20472510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials.
    Alev L; Fujikoshi S; Yoshikawa A; Enomoto H; Ishida M; Tsuji T; Ogawa K; Konno S
    J Pain Res; 2017; 10():1723-1731. PubMed ID: 28769588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study.
    Uchio Y; Enomoto H; Ishida M; Tsuji T; Ochiai T; Konno S
    J Pain Res; 2018; 11():1391-1403. PubMed ID: 30104894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in anxiety during treatment with exercise and duloxetine is related to improvement of low back pain-related disability in patients with non-specific chronic low back pain.
    Onda A; Kimura M
    Fukushima J Med Sci; 2020; 66(3):148-155. PubMed ID: 33298637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to duloxetine in patients with knee pain due to osteoarthritis: an exploratory post hoc analysis of a Japanese Phase III randomized study.
    Itoh N; Tsuji T; Ishida M; Ochiai T; Konno S; Uchio Y
    J Pain Res; 2018; 11():2603-2616. PubMed ID: 30464579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
    Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
    J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of duloxetine in patients with knee osteoarthritis or chronic low back pain with early pain reduction: An exploratory post-hoc analysis of Japanese phase 3, 1-year extension studies.
    Itoh N; Uchio Y; Tsuji T; Ishida M; Ochiai T; Konno S
    J Orthop Sci; 2022 May; 27(3):717-724. PubMed ID: 33958268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of duloxetine by prior NSAID use in the treatment of chronic osteoarthritis knee pain: A post hoc subgroup analysis of a randomized, placebo-controlled, phase 3 study in Japan.
    Enomoto H; Fujikoshi S; Tsuji T; Sasaki N; Tokuoka H; Uchio Y
    J Orthop Sci; 2018 Nov; 23(6):1019-1026. PubMed ID: 30126675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
    Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
    Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data.
    Wang G; Bi L; Li X; Li Z; Zhao D; Chen J; He D; Wang CN; Wu T; Dueñas H; Skljarevski V; Yue L
    BMC Musculoskelet Disord; 2019 Apr; 20(1):174. PubMed ID: 31010413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trials.
    Williamson OD; Schroer M; Ruff DD; Ahl J; Margherita A; Sagman D; Wohlreich MM
    Clin Ther; 2014 Apr; 36(4):544-51. PubMed ID: 24650448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is immediate imaging important in managing low back pain?
    Andersen JC
    J Athl Train; 2011; 46(1):99-102. PubMed ID: 21214357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.